Insider Transactions Reported by 12 Insiders of Scinai Immunotherapeutics Ltd.

Symbol
SCNI on Nasdaq
Location
Jerusalem, Israel

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Scinai Immunotherapeutics Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samuel J. Moed Director 01 Jan 2023
George H. Lowell Director 01 Jan 2023
Morris C. Laster Director 01 Jan 2023
YAEL MARGOLIN Director 01 Jan 2023
Adi Raviv Director 01 Jan 2023
Elad Mark Chief Operating Officer 01 Jan 2023
Jay Green Director 01 Jan 2023
Mark Germain Director, Chairman 01 Jan 2023
Avner Rotman Director 01 Jan 2023
Amir Reichman Chief Executive Officer, Director 01 Jan 2023
Tamar Ben-Yedidia Chief Scientist 01 Jan 2023
Uri Ben-Or Chief Financial Officer 01 Jan 2023

Recent Insider Transactions by Companies or Individuals for Scinai Immunotherapeutics Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Yael Margolin SCNI Ordinary Shares 0 66,800 01 Jan 2023 Direct
Morris C. Laster SCNI Ordinary Shares 0 66,800 01 Jan 2023 Direct
George H. Lowell SCNI Ordinary Shares 0 421,680 01 Jan 2023 Direct
Avner Rotman SCNI Ordinary Shares 0 66,800 01 Jan 2023 Direct
Avner Rotman SCNI Ordinary Shares 0 138,780 01 Jan 2023 Direct
Adi Raviv SCNI Ordinary Shares 0 66,800 01 Jan 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.